FDA Approved: RIFAMPIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a Lupin Pharmaceuticals supplemental application for Rifampin (ANDA 090034), resulting in an approved update to the generic Rifampin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)